We are live on
!
Find out more
IP
Intellectus Partners Portfolio holdings
AUM
$578M
Turnover
15.36%
1-Year Est. Return
49.48%
This Fund
S&P 500
This Quarter
Est. Return
-5.33%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$335M
AUM Growth
-$57.3M
(-15%)
Cap. Flow
-$28.3M
Cap. Flow
% of AUM
-8.44%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
289
New
17
Increased
84
Reduced
117
Closed
55
Avg Time Held
2.5
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DocuSign
DOCU
|
+$1.31M |
| 2 |
BlackRock Municipal Income Fund, Inc.
MUI
|
+$779K |
| 3 |
American Express
AXP
|
+$752K |
| 4 |
PayPal
PYPL
|
+$683K |
| 5 |
Texas Instruments
TXN
|
+$620K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Confluent
CFLT
|
+$2.11M |
| 2 |
Taboola.com
TBLA
|
+$1.86M |
| 3 |
TotalEnergies
TTE
|
+$1.54M |
| 4 |
Strata Critical Medical Inc
SRTA
|
+$1.54M |
| 5 |
Coinbase
COIN
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.36% |
| 2 | Technology | 18.73% |
| 3 | Healthcare | 15.93% |
| 4 | Consumer Discretionary | 15.19% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
DELISTED
Luminar Technologies
LAZR
| $699K | 0.21% |
2,980
-316
| -10% | -$69.3K |
2020 Q3
6 quarters
|
|
127
Advance Auto Parts
AAP
$2.65B
| $688K | 0.21% |
3,298
-239
| -7% | -$52.6K |
2018 Q4
13 quarters
|
|
128
Centene
CNC
$34.8B
| $677K | 0.2% |
8,047
-546
| -6% | -$44.8K |
2020 Q3
6 quarters
|
|
129
Parker-Hannifin
PH
$121B
| $674K | 0.2% |
2,376
+49
| +2% | +$14.8K |
2021 Q2
3 quarters
|
|
130
Relay Therapeutics
RLAY
$3.79B
| $673K | 0.2% |
22,470
-3,700
| -14% | -$89.8K |
2020 Q4
5 quarters
|
|
131
Merck
MRK
$358B
| $671K | 0.2% |
8,111
-132
| -2% | -$10.4K |
2021 Q2
3 quarters
|
|
132
Western Digital
WDC
$133B
| $662K | 0.2% |
17,629
+3,440
| +24% | +$141K |
2021 Q2
3 quarters
|
|
133
Biogen
BIIB
$34.8B
| $661K | 0.2% |
3,140
+1,120
| +55% | +$244K |
2016 Q4
21 quarters
|
|
134
Intuitive Surgical
ISRG
$151B
| $660K | 0.2% |
2,188
+130
| +6% | +$38K |
2020 Q3
6 quarters
|
|
135
Vanguard Morningstar Growth ETF
VUG
$232B
| $653K | 0.19% |
13,620
-2,400
| -15% | -$114K |
2019 Q4
9 quarters
|
|
136
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$328M
| $645K | 0.19% |
31,500
-20,450
| -39% | -$393K |
2020 Q3
6 quarters
|
|
|
137
Texas Instruments
TXN
$255B
| $645K | 0.19% |
+3,515
| New | +$620K |
2022 Q1
0 quarters
|
|
138
Altria Group
MO
$123B
| $640K | 0.19% |
12,045
+103
| +0.9% | +$5.25K |
2017 Q2
19 quarters
|
|
139
Teladoc Health
TDOC
$1.08B
| $637K | 0.19% |
8,830
+5
| +0.1% | +$360 |
2020 Q4
5 quarters
|
|
140
Lam Research
LRCX
$347B
| $633K | 0.19% |
11,740
+1,520
| +15% | +$88.5K |
2021 Q2
3 quarters
|
|
141
Zoetis
ZTS
$32.4B
| $632K | 0.19% |
3,351
-2,353
| -41% | -$465K |
2016 Q4
21 quarters
|
|
142
Schwab US TIPS ETF
SCHP
$16.3B
| $629K | 0.19% |
20,728
| – | – |
2020 Q4
5 quarters
|
|
143
Iovance Biotherapeutics
IOVA
$6.67B
| $626K | 0.19% |
37,600
-2,500
| -6% | -$38.7K |
2019 Q4
9 quarters
|
|
144
CRISPR Therapeutics
CRSP
$4.98B
| $621K | 0.19% |
9,890
-1,000
| -9% | -$62.8K |
2019 Q4
9 quarters
|
|
145
Norfolk Southern
NSC
$73B
| $616K | 0.18% |
2,159
+53
| +3% | +$14.6K |
2021 Q4
1 quarter
|
|
146
Spotify
SPOT
$110B
| $608K | 0.18% |
4,028
-152
| -4% | -$25.9K |
2020 Q4
5 quarters
|
|
147
Nike
NKE
$55.2B
| $597K | 0.18% |
4,429
-273
| -6% | -$38.4K |
2016 Q4
21 quarters
|
|
148
Baidu
BIDU
$28.1B
| $594K | 0.18% |
4,493
-10
| -0.2% | -$1.51K |
2017 Q2
19 quarters
|
|
149
Eli Lilly
LLY
$1.12T
| $586K | 0.17% |
2,046
+19
| +0.9% | +$4.89K |
2021 Q2
3 quarters
|
|
150
PepsiCo
PEP
$175B
| $586K | 0.17% |
3,500
| – | – |
2020 Q1
8 quarters
|
|
Similar funds
AFGAS
AHL
CTAF
HIM
SSP
CA
PWM
MFS
Intellectus Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Intellectus Partners held 289 positions worth $335M, down 15% from $392M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Intellectus Partners withdrew a net $28.3M in Q1 2022, closing 55 positions and reducing 117 holdings. Its most notable exit was Confluent, an estimated $2.11M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Intellectus Partners opened a new position in American Express worth $778K.
- Intellectus Partners's largest Q1 2022 buy was American Express: 4,162 shares worth $778K.
- Intellectus Partners added most to DocuSign in Q1 2022, an estimated $1.31M increase.
- Intellectus Partners's biggest Q1 2022 reduction was Alphabet (Google) Class A, cutting an estimated $1.09M.
- Intellectus Partners fully exited Confluent in Q1 2022, selling an estimated $2.11M.
- Intellectus Partners's ten largest holdings make up 29% of its $335M portfolio in Q1 2022.
- Intellectus Partners opened 17 new positions and closed 55 in Q1 2022.
- Intellectus Partners's portfolio value fell 15% quarter-over-quarter to $335M.
Based on Intellectus Partners's 13F filing for Q1 2022, filed 16 May 2022.